A deep learning-informed interpretation of why and when dose metrics outside the PTV can affect the risk of distant metastasis in SBRT NSCLC patients
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: A deep model and explainable analysis identified dose and tumor features associated with distant metastasis in a 478-patient stereotactic-body-radiotherapy cohort; this is a retrospective association, not causal evidence.
Technology: Deep-learning metastasis-risk model with explainable feature analysis
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Deep-learning metastasis-risk model with explainable feature analysis
- Limitation / still unknown
- The reported association does not establish causation; transfer beyond the stated cohorts and any practical benefit were not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/article/10.1186/s13014-024-02519-1 · https://doi.org/10.1186/s13014-024-02519-1
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.